$QBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Q BioMed Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Q BioMed Inc.. Get notifications about new insider transactions in Q BioMed Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Grant | A | 0.00 | 35,000 | 0 | 653,761 | 618.8 K to 653.8 K (+5.66 %) |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 1.03 | 500,000 | 515,000 | 2,500,000 | |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 1.50 | 150,000 | 225,000 | 2,000,000 | |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 1.50 | 150,000 | 225,000 | 1,850,000 | |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 1.03 | 500,000 | 515,000 | 3,148,461 | |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 1.50 | 150,000 | 225,000 | 2,648,461 | |
| Nov 19 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 1.50 | 150,000 | 225,000 | 2,498,461 | |
| Apr 08 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 2.12 | 225,000 | 477,000 | 2,398,461 | |
| Feb 21 2020 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 2.12 | 750,000 | 1,590,000 | 1,700,000 | |
| Feb 21 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 2.12 | 750,000 | 1,590,000 | 2,173,461 | |
| Feb 21 2020 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 2.12 | 750,000 | 1,590,000 | 1,700,000 | |
| Feb 21 2020 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 2.12 | 750,000 | 1,590,000 | 2,173,461 | |
| Jan 17 2020 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Option Exercise | A | 1.50 | 150,000 | 225,000 | 500,000 | |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Option Exercise | A | 1.25 | 150,000 | 187,500 | 350,000 | |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Option Exercise | A | 1.25 | 150,000 | 187,500 | 200,000 | |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Option Exercise | A | 3.00 | 37,500 | 112,500 | 50,000 | |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 500 | 0 | 15,500 | 15 K to 15.5 K (+3.33 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 2,000 | 0 | 15,000 | 13 K to 15 K (+15.38 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 500 | 0 | 13,000 | 12.5 K to 13 K (+4.00 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 1,500 | 0 | 12,500 | 11 K to 12.5 K (+13.64 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 1,000 | 0 | 11,000 | 10 K to 11 K (+10.00 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 2,500 | 0 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 1,500 | 0 | 7,500 | 6 K to 7.5 K (+25.00 %) |
| Nov 12 2019 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Grant | A | 0.00 | 1,500 | 0 | 6,000 | 4.5 K to 6 K (+33.33 %) |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 1.25 | 100,000 | 125,000 | 950,000 | |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 1.25 | 50,000 | 62,500 | 850,000 | |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 2.11 | 6,400 | 13,530 | 2,435,400 | 2.4 M to 2.4 M (-0.26 %) |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 0.86 | 173,641 | 149,331 | 1,423,461 | |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 1.25 | 100,000 | 125,000 | 1,250,000 | |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 1.25 | 50,000 | 62,500 | 1,150,000 | |
| Nov 06 2019 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Grant | A | 0.00 | 115,761 | 0 | 618,761 | 503 K to 618.8 K (+23.01 %) |
| Jul 11 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 2.85 | 7,000 | 19,934 | 2,441,800 | 2.4 M to 2.4 M (-0.29 %) |
| Jul 11 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.37 | 7,000 | 23,578 | 2,448,800 | 2.5 M to 2.4 M (-0.29 %) |
| Jul 09 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.58 | 6,900 | 24,690 | 2,455,800 | 2.5 M to 2.5 M (-0.28 %) |
| Jul 09 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.54 | 6,600 | 23,342 | 2,462,700 | 2.5 M to 2.5 M (-0.27 %) |
| Jul 02 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.40 | 2,100 | 7,138 | 2,473,500 | 2.5 M to 2.5 M (-0.08 %) |
| Jul 02 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.39 | 5,300 | 17,961 | 2,475,600 | 2.5 M to 2.5 M (-0.21 %) |
| Jun 28 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.44 | 4,900 | 16,833 | 2,480,900 | 2.5 M to 2.5 M (-0.20 %) |
| Jun 28 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.43 | 3,800 | 13,033 | 2,485,800 | 2.5 M to 2.5 M (-0.15 %) |
| Jun 28 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.42 | 1,400 | 4,785 | 2,489,600 | 2.5 M to 2.5 M (-0.06 %) |
| Jun 25 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Buy | S | 3.45 | 3,300 | 11,388 | 2,491,000 | 2.5 M to 2.5 M (+0.13 %) |
| Jun 25 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Sell | S | 3.47 | 5,700 | 19,765 | 2,494,300 | 2.5 M to 2.5 M (-0.23 %) |
| Jun 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 3.35 | 100,000 | 335,000 | 1,100,000 | |
| Jun 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 3.35 | 50,000 | 167,500 | 1,000,000 | |
| Jun 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 25,000 | 100,000 | 950,000 | |
| Jun 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 12,500 | 50,000 | 925,000 | |
| Jun 06 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | P | 3.35 | 100,000 | 335,000 | 775,000 | |
| Jun 06 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | P | 3.35 | 50,000 | 167,500 | 675,000 | |
| Jun 06 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | P | 4.00 | 25,000 | 100,000 | 625,000 | |
| Jun 06 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 4.00 | 12,500 | 50,000 | 600,000 | |
| Mar 13 2018 | QBIO | Q BioMed Inc. | Panicucci Rick | Director | Option Exercise | A | 3.00 | 12,500 | 37,500 | 12,500 | |
| Mar 08 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 4.00 | 25,000 | 100,000 | 612,500 | |
| Mar 08 2018 | QBIO | Q BioMed Inc. | Corin Denis | Chief Executive Off ... | Option Exercise | A | 4.00 | 12,500 | 50,000 | 587,500 | |
| Mar 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 25,000 | 100,000 | 912,500 | |
| Mar 08 2018 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 12,500 | 50,000 | 887,500 | |
| Dec 19 2017 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 4.00 | 25,000 | 100,000 | 575,000 | |
| Dec 19 2017 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 4.00 | 12,500 | 50,000 | 550,000 | |
| Dec 19 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 25,000 | 100,000 | 875,000 | |
| Dec 19 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | Chief Legal Officer | Option Exercise | A | 4.00 | 12,500 | 50,000 | 850,000 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 4.00 | 350,000 | 1,400,000 | 437,500 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 4.00 | 25,000 | 100,000 | 187,500 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 4.00 | 12,500 | 50,000 | 162,500 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 4.00 | 350,000 | 1,400,000 | 437,500 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 4.00 | 25,000 | 100,000 | 187,500 | |
| Oct 04 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 4.00 | 12,500 | 50,000 | 162,500 | |
| Apr 19 2017 | QBIO | Q BioMed Inc. | LINDSAY ALAN P | 10% Owner | Sell | S | 5.25 | 2,000 | 10,500 | 1,262,245 | 1.3 M to 1.3 M (-0.16 %) |
| Apr 19 2017 | QBIO | Q BioMed Inc. | LINDSAY ALAN P | 10% Owner | Sell | S | 5.88 | 2,400 | 14,112 | 1,264,245 | 1.3 M to 1.3 M (-0.19 %) |
| Apr 19 2017 | QBIO | Q BioMed Inc. | LINDSAY ALAN P | 10% Owner | Sell | S | 6.16 | 2,500 | 15,400 | 1,266,645 | 1.3 M to 1.3 M (-0.20 %) |
| Apr 19 2017 | QBIO | Q BioMed Inc. | LINDSAY ALAN P | 10% Owner | Sell | S | 6.54 | 5,000 | 32,700 | 1,269,145 | 1.3 M to 1.3 M (-0.39 %) |
| Apr 14 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 7.60 | 5,000 | 38,000 | 975,549 | 980.5 K to 975.5 K (-0.51 %) |
| Apr 14 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 5.29 | 4,400 | 23,276 | 980,549 | 984.9 K to 980.5 K (-0.45 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 5.09 | 5,000 | 25,450 | 36,949 | 41.9 K to 36.9 K (-11.92 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.72 | 5,000 | 23,600 | 41,949 | 46.9 K to 41.9 K (-10.65 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.56 | 3,700 | 16,872 | 46,949 | 50.6 K to 46.9 K (-7.31 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.71 | 5,000 | 23,550 | 50,649 | 55.6 K to 50.6 K (-8.98 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.87 | 5,000 | 19,350 | 55,649 | 60.6 K to 55.6 K (-8.24 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.40 | 2,200 | 7,480 | 60,649 | 62.8 K to 60.6 K (-3.50 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.39 | 1,900 | 6,441 | 62,849 | 64.7 K to 62.8 K (-2.93 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 2.90 | 100 | 290 | 64,749 | 64.8 K to 64.7 K (-0.15 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.25 | 1,200 | 3,900 | 64,849 | 66 K to 64.8 K (-1.82 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.56 | 3,800 | 13,528 | 66,049 | 69.8 K to 66 K (-5.44 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.73 | 900 | 3,357 | 69,849 | 70.7 K to 69.8 K (-1.27 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.37 | 5,000 | 16,850 | 70,749 | 75.7 K to 70.7 K (-6.60 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.86 | 1,800 | 6,948 | 75,749 | 77.5 K to 75.7 K (-2.32 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.00 | 1,000 | 4,000 | 77,549 | 78.5 K to 77.5 K (-1.27 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 3.27 | 4,651 | 15,209 | 78,549 | 83.2 K to 78.5 K (-5.59 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.38 | 5,000 | 21,900 | 83,200 | 88.2 K to 83.2 K (-5.67 %) |
| Mar 30 2017 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Sell | S | 4.40 | 3,800 | 16,720 | 88,200 | 92 K to 88.2 K (-4.13 %) |
| Dec 14 2016 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 1.45 | 37,500 | 54,375 | 2,650,000 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 1.45 | 37,500 | 54,375 | 2,612,500 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 1.45 | 37,500 | 54,375 | 2,575,000 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | CORIN DENIS | Chief Executive Off ... | Option Exercise | A | 1.45 | 37,500 | 54,375 | 2,537,500 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 1.45 | 37,500 | 54,375 | 10,075,000 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 1.45 | 37,500 | 54,375 | 1,037,500 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 1.45 | 37,500 | 54,375 | 1,000,000 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | A | 1.45 | 37,500 | 54,375 | 962,500 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Option Exercise | P | 1.45 | 50,000 | 72,500 | 925,000 | |
| Dec 14 2016 | QBIO | Q BioMed Inc. | Rosenstadt William S | General Counsel | Gift | G | 0.00 | 25,000 | 0 | 1,050,000 | 1.1 M to 1.1 M (-2.33 %) |
Page: 1